- Filed
- May 6, 2025 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2025 · Apr 30, 2025 | 26.08M sh |
| Capex | Q1 2025 · Mar 31, 2025 | $0 |
| Capex | Q1 2025 · Mar 31, 2024 | $15K |
| Cash And Equivalents | Q1 2025 · Mar 31, 2025 | $33.8M |
| Cash And Equivalents | Q1 2025 · Dec 31, 2024 | $48.28M |
| Current Liabilities | Q1 2025 · Mar 31, 2025 | $10.73M |
| Current Liabilities | Q1 2025 · Dec 31, 2024 | $13.15M |
| Total Liabilities | Q1 2025 · Mar 31, 2025 | $44.92M |
| Total Liabilities | Q1 2025 · Dec 31, 2024 | $47.09M |
| Current Assets | Q1 2025 · Mar 31, 2025 | $45.21M |
| Current Assets | Q1 2025 · Dec 31, 2024 | $58.96M |
| Total Assets | Q1 2025 · Mar 31, 2025 | $82.78M |
| Total Assets | Q1 2025 · Dec 31, 2024 | $97.84M |
| Shares Diluted restated | Q1 2025 · Mar 31, 2024 | 4.57M sh |
| Operating Cash Flow | Q1 2025 · Mar 31, 2024 | −$11.68M |
| Stockholders Equity | Q1 2025 · Mar 31, 2024 | $56.09M |
| Stockholders Equity | Q1 2025 · Dec 31, 2023 | $66.91M |
| Eps Diluted restated | Q1 2025 · Mar 31, 2024 | −$2.65 |
| Eps Basic restated | Q1 2025 · Mar 31, 2024 | −$2.65 |
| Sga Expense | Q1 2025 · Mar 31, 2024 | $7.52M |
| Rd Expense | Q1 2025 · Mar 31, 2024 | $8.78M |
| Net Income | Q1 2025 · Mar 31, 2024 | −$12.11M |
| Operating Income | Q1 2025 · Mar 31, 2024 | −$16.3M |